GLP-1 receptor agonists linked to lower mortality for patients with brain metastases, T2DM

[
For patients with cancer and brain metastases (BM) and type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with significantly lower all-cause mortality, according to a research letter published online March 11 in JAMA Network Open.


Source link

Views: 2

See also  Middle-aged women use testosterone therapy to boost sex life

Check Also

Brain tumors: 3D experimental system to evaluate candidate drugs against glioma

[ Glioma is a tumor of the central nervous system that originates from glial cells, …

How our research led to a privacy complaint that pushed the World Anti‑Doping Agency to change its rules

[ The Privacy Commissioner of Canada recently announced the outcome of its investigation into the …

Fat-producing enzyme may amplify damage in Parkinson’s disease

[ Credit: Image generated by the editorial team using AI for illustrative purposes. A fat-producing …

Leave a Reply

Available for Amazon Prime
A comparação entre experiências de apostas online está cada vez.